Vericel Corp

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$40.10

+0.97 (+2.48%)

As of Jun 21, 10:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +8.7% upside

Low Target $27.22

Average Target $43.60

High Target $49.94

Current Price $40.10

Current
$40.10

Target
$43.60

$27.22 $43.60 avg $49.94

Scenario Analysis

Bear Case

$27.22

-32.1%

Low target

Base Case

$43.60

+8.7%

Avg target

Bull Case

$49.94

+24.5%

High target

Risk/Reward

0.8x

Unfavorable

Price in Context

52-Week High

$43.57

-8.0% from high

52-Week Low

$28.95

+38.5% from low

Target vs 52W High

$43.60

+0.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.7%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+189.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-7.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.2%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%